0.00Open0.00Pre Close0 Volume0 Open Interest92.00Strike Price0.00Turnover180.51%IV-20.40%PremiumDec 20, 2024Expiry Date15.59Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8297Delta0.0187Gamma4.58Leverage Ratio-0.4689Theta-0.0069Rho-3.80Eff Leverage0.0191Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet